In breast cancer, IL-33 secreted by cancer-associated fibroblasts enhances ILC2 and Th2 type responses, induces the TCR-independent secretion of IL-13, and recruits immunosuppressive granulocytes [121]. This evidence concerns the gene IL13 and breast carcinoma.